During the past decade, Toyota Kosei Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Toyota Kosei Hospital" are "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials), "Respiratory Syncytial Virus Infections" (1 trials) and "Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)" (1 trials). Many other conditions were trialed in "Toyota Kosei Hospital" in a lesser frequency.

Most popular intervention types in "Toyota Kosei Hospital" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bedaquiline" (1 trials), "Clarithromycin" (1 trials), "Ethambutol" (1 trials) and "Golimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toyota Kosei Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Toyota Kosei Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Toyota Kosei Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toyota Kosei Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".